INGELHEIM, Germany, October 22 /PRNewswire/ --

- BI 6727, a Highly Potent and Selective Plk1 inhibitor, Represents Latest Advance in Company's Plk1 Programme

- For non-US Healthcare Media

LONDON, October 22 /PRNewswire/ --

- Unite Survey Reveals Longer Waiting Times and Stressed Workforce

The speech and language therapy service is 'heading towards crisis', a new survey of the profession by Unite, the largest union in the country, has revealed.

Unite, which represents 5,500 speech and language therapists (SALTS) and SALT assistants, said that this means longer waiting and referral times for patients and clients, while the workforce becomes more stressed and demoralised.

Unite's Lead Officer for SALT members, Fiona Farmer said: 'The survey of our reps paints a service heading towards crisis, with our members having to introduce priority lists and preside over a decline in specialist services.'

PORTON DOWN, England, October 22 /PRNewswire/ --

Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today that it has signed a third licence agreement with Applied Biosystems.

The licence provides Enigma with access to claims of US Patent No. 5,928,907 that describe methods for monitoring nucleic acid amplification in real-time. This is the first such licence Applied Biosystems has granted to the method claims of the '907 patent.

This complements Enigma's existing licence under certain patents owned by Applied Biosystems for real-time PCR thermal cyclers.

Financial terms were not disclosed.

WALTHAM, Massachusetts, October 22 /PRNewswire/ --

- Significant Unmet Need Remains for Agents that are Effective in Treating Triple-Negative Breast Cancer, According to a New Report from Decision Resources

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that significant market penetration will drive Genentech/Roche/Chugai's Avastin to garner just over 20 percent of total sales in the breast cancer drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan in 2017.

PARIS, October 22 /PRNewswire/ --

South Korean-based SK Engineering and Construction (SKEC) is using Quadrem solutions to manage sourcing and procurement communications with an international community of 5,000 suppliers. Approximately 300 to 400 tenders are expected to be issued by SKEC to support a gas train project it's undertaking in the Middle East for a national petroleum company.

We chose Quadrem to handle Web-based sourcing and procurement for this USD $2 billion project because we must provide excellent management of worldwide suppliers, said Mr. Oh-Young LEE, Project Procurement Chief Manager of the Fourth Gas Train Project Team, SKEC.

COPENHAGEN, Denmark, October 22 /PRNewswire/ -- Zecure, a leading provider of e-commerce fraud prevention solutions, today announced that OrbitalPay, LLC has installed its award-winning Acquirer SAFE suite to prevent fraudulent merchants from hiding illegal transactions and to keep high risk merchants under control.

Acquirer SAFE helps Acquiring Banks and Payment Service Providers (PSPs) keep high-risk merchants under control and prevent them from processing illegal transactions disguised as legitimate ones. Acquirer SAFE enables acquirers and PSPs to identify a transaction's true origin based on the behavior of shoppers on the merchant's website.

LONDON, October 22 /PRNewswire/ -- Today at SYSTEMS 08, Telnic Limited, the Registry Operator for the new .tel Top Level Domain (TLD) announced that one hundred ICANN-accredited registrars had signed an agreement to sell .tel domain names well in advance of its launch.

The one hundredth registrar to sign was Network Solutions, which ranks third largest in the world with the number of domains under management. The first registrar to sign up to distribute .tel was European domain specialist EuroDNS.

Researchers from McGill University, the California Institute of Technology, the Curie Institute in Paris, Princeton University and other institutions, have unearthed crystalline magnetic fossils of a previously unknown species of microorganism that lived at the boundary of the Paleocene and Eocene epochs, some 55 million years ago. The research might help scientists understand more thoroughly the potential effects of significant changes in the Earth's climate. Though they are only some four microns long, these newly discovered, spear-shaped magnetite crystals (magnetofossils) – unearthed at a dig in New Jersey – are up to eight times larger than previously known magnetofossils.

A drug which was developed in Cambridge and initially designed to treat a form of leukaemia has also proven effective against combating the debilitating neurological disease multiple sclerosis (MS).

The study, led by researchers from the University of Cambridge, has found that alemtuzumab not only stops MS from advancing in patients with early stage active relapsing-remitting multiple sclerosis (RRMS) but may also restore lost function caused by the disease. The findings were published today in the New England Journal of Medicine.

Chandrayaan-1, India’s first mission to the Moon, was successfully launched earlier this morning from the Satish Dhawan Space Centre (SHAR) in Sriharikota, India.

The PSLV-C11 rocket, an upgraded version of the Indian Space Research Organization’s (ISRO’s) Polar Satellite Launch Vehicle, lifted off at 02:52 Central European Summer Time (CEST) and injected the spacecraft into a highly elongated orbit around the Earth. 

Chandrayaan-1 is led by ISRO and the international partners include ESA, Bulgaria and the USA.